Odds ratio of programmed cell death-1 or ligand 1 inhibitor-related endocrine dysfunction in patients with lung cancer: A systematic review and meta-analysis

PURPOSE: We designed the study to investigate the incidence risk of Programmed Cell Death-1 (PD-1) or Ligand 1 (PD-L1) inhibitor-related endocrine dysfunction in patients with lung cancer. METHOD: All the data were collected by 1 primary reviewer and then independently reviewed by 2 secondary review...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Jian, Zhang, Zewen, Zhang, Shuisheng, Lv, Yajuan, Mao, Yantao, Liu, Rujun, Tian, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922418/
https://www.ncbi.nlm.nih.gov/pubmed/31852114
http://dx.doi.org/10.1097/MD.0000000000018310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922418/
https://www.ncbi.nlm.nih.gov/pubmed/31852114
http://dx.doi.org/10.1097/MD.0000000000018310

Ejemplares similares